Career Oportunities

Career Prospects in the Global Market

Central and Eastern Europe

Drugs developed with data coming from studies conducted in Russia have begun to be approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) – the most important quality marker an emerging country could attain.

Latin America

BMS (Bristol-Myers Squibb) has created research hubs around the world for clinical research operations, three of which are located in Latin America namely Mexico, Brazil, Argentina.

India

India’s pharmaceutical market is already substantial at USD 9.4 Billion and is projected to increase at 7.2% per year for the next (3) three years.

*(Source: Centerwatch Bookstore/ Emerging Market in Clinical Research by Sara Gambrill)